Content related to Back to the Basics: Understanding the Genetics of Cancer

5 Questions for Jeri Wilson, Executive Director of the Pediatric Cancer Research Foundation

Microscopic image: MDM2 expression (in red) in retinoblastoma Rb176 cells. Credit: Donglai Qi, PhD, and David Cobrinik, MD, PhD. Researchers at The Saban Research Institute of Children’s Hospital Los

Research at Children’s Hospital Los Angeles enables a novel compound to achieve a key designation from the Food and Drug Administration.

A new study from Children’s Hospital Los Angeles found that a specific pathway may be driving tumor growth in Ewing sarcoma.

Yves De Clerck, MD

Investigators at the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles have identified new findings about an immune cell – called a tumor-associated macrophage – that

Researchers are working to uncover a cause for retinoblastoma, the most common eye cancer in children. They have published promising results in the journal Nature.

Retinoblastoma is a common eye cancer in children. David Cobrinik of The Vision Center has helped answer the question of why mutations to the RB1 gene primarily cause tumors of the retina.

A physician-scientist is harnessing the power of zebrafish—and a new, state-of-the-art facility—to develop innovative treatments for solid tumors in children.